AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today reported results for the full year ended December 31, ...
The engine-turbocharger maker’s stock rose after it posted higher earnings, exceeded $1 billion in revenue for the first time ...
The engine-turbocharger maker’s stock rose after it posted higher earnings, exceeded $1 billion in revenue for the first time ...
Accelleron Industries AG / Key word (s): Annual Results Accelleron breaks through the USD 1 billion revenue mark 13-March-2025 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR ...
Swiss finance app Yuh becomes profitable ahead of schedule, surpassing 300,000 users and doubling customer assets to 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback